Inflammasome Therapeutics is focused on developing therapies for degenerative diseases such as Alzheimer’s disease, multiple sclerosis, macular degeneration, and Parkinson's disease.

By focusing on Inflammasome activation, we are working to treat these diseases through a new, innovative approach.

Explore Our Approach